AtriCure ATRC Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | -$44.7M-46.8% | -$30.44M+34.5% | -$46.47M— | ||
| $12.09M+7.8% | $11.21M+18.5% | $9.46M+17.4% | $8.06M+6.9% | ||
| $44.69M+10.6% | $40.41M+13.1% | $35.73M+24.2% | $28.77M+2.5% | ||
| $478K0.0% | $478K-1.6% | $486K-4.1% | $507K-33.2% | ||
| —— | —— | $9.87M+9.8% | $8.99M— | ||
| —— | —— | $21.83M+199% | $7.31M+70.9% | ||
| —— | -$1.53M-124% | $6.3M— | —— | ||
| $7M— | —— | $11.56M— | —— | ||
| —— | $2.18M+44.7% | $1.5M— | —— | ||
| $8.44M+12.3% | $7.52M+40.5% | $5.35M+46.5% | $3.65M-95.6% | ||
| —— | —— | —— | $515K— | ||
| $57.33M+370% | $12.2M+172% | $4.48M— | —— | ||
| $9.05M-21.0% | $11.46M-4.5% | $12M-28.9% | $16.88M+73.1% | ||
| -$14.55M— | —— | —— | $47.25M— | ||
| $1.2M-98.1% | $62.88M+6,239% | $992K+10.3% | $899K— | ||
| $11.16M+60.6% | $6.95M+6.0% | $6.56M-46.3% | $12.2M-32.3% | ||
| $0-100% | $1.07M— | —— | $0— | ||
| —— | —— | —— | —— | ||
| $773K+282% | -$424K— | —— | —— | ||
| $44.71M— | —— | —— | —— | ||
| $5.26M-11.7% | $5.95M-6.7% | $6.38M+49.3% | $4.27M+1.1% | ||
| —— | $619K+56.7% | $395K+106% | $192K+1.1% | ||
| $478K0.0% | $478K-1.6% | $486K-4.1% | $507K-33.2% | ||
| $8.44M+12.3% | $7.52M+40.5% | $5.35M+46.5% | $3.65M+25.7% | ||
| $12.09M+7.8% | $11.21M+18.5% | $9.46M+17.4% | $8.06M+6.9% | ||
| —— | —— | —— | $515K— | ||
| $2.13M+106% | $1.04M-13.2% | $1.19M-33.1% | $1.78M-35.6% | ||
| $0-100% | $1.07M— | —— | $0— | ||
| $1.2M-98.1% | $62.88M+6,239% | $992K+10.3% | $899K— | ||
| —— | $0— | $0— | —— | ||
| —— | —— | —— | —— | ||
| —— | $619K+56.7% | $395K+106% | $192K+1.1% | ||
| $48.28M— | —— | —— | -$39.07M-66.0% | ||
| $48.28M— | —— | —— | -$39.07M-66.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AtriCure generate?
- AtriCure (ATRC) generated $64.4M in operating cash flow over the trailing twelve months.
- What is AtriCure's free cash flow?
- After $10.7M of capital expenditures, AtriCure's free cash flow was $53.6M over the trailing twelve months, up 249.2% year over year.
- Where does AtriCure's cash flow data come from?
- Every line is extracted from AtriCure's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
